Have a personal or library account? Click to login
Review: comparing platelet compatibility to red cell compatibility protocols Cover

Review: comparing platelet compatibility to red cell compatibility protocols

By:
Paid access
|Nov 2020

References

  1. Surgenor DM, Wallas EL, Hao SHS, Chapman RH. Collection and transfusion of blood in the United States, 1982-1988. New Eng J Med 1990;322:1646–51.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1056/NEJM199006073222306" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1056/NEJM199006073222306</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">2342524</dgpm:pub-id>
  2. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 9th ed. Oxford: Blackwell Scientific Publications 1993;391-4;112;453.
  3. Tomasulo PA, Petz LD. Platelet transfusions. In: Petz LD, Swisher SN, eds. Clinical practice of transfusion medicine. 2nd ed. New York: Churchill Livingstone, 1989:427–87.
  4. Slichter SJ. Platelet alloimmunization. In: Anderson KC, Ness PM, eds. Scientific basis of transfusion medicine. Implications for clinical practice. Philadelphia: WB Saunders Co., 1994:527–8.
  5. Dutcher JP, Schiffer CA, Aisner J, Wiernik PH. Long-term followup of patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized. Blood 1981;58:1007–11.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1182/blood.V58.5.1007.1007" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1182/blood.V58.5.1007.1007</a></dgdoi:pub-id>
  6. Holohan TV, Terasaki PI, Deisseroth AB. Suppression of transfusion-related alloimmunization in intensively treated cancer patients. Blood 1981;58:122–8.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1182/blood.V58.1.122.122" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1182/blood.V58.1.122.122</a></dgdoi:pub-id>
  7. Kickler TS. Platelet immunology. In: Anderson KC, Ness PM, eds. Scientific basis of transfusion medicine. Implications for clinical practice. Philadelphia: WB Saunders Co., 1994:308.
  8. Walker RH, ed. Technical manual. 11th ed. Bethesda, MD: American Association of Blood Banks, 1993:309–15.
  9. Hogge DE, Dutcher JP, Aisner J, Schiffer CA. Lymphocytotoxic antibody as a predictor of response to random donor platelet transfusion. Am J Hematol 1983;14:363–9.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1002/ajh.2830140407" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/ajh.2830140407</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">6859034</dgpm:pub-id>
  10. Comenzo RL, Malachowski MD, Berkman EM. Determining the dose of platelets for transfusion. In: Kurtz SR, Brubaker DB, eds. Clinical decisions in platelet therapy. Bethesda, MD: American Association of Blood Banks, 1992:6–7.
  11. Daly PA, Schiffer CA, Aisner J, Wiernik PH. Platelet transfusion therapy: one-hour post-transfusion increments are valuable in predicting the need for HLA-matched preparations. JAMA 1980;243:435–8.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1001/jama.1980.03300310023016" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1001/jama.1980.03300310023016</a></dgdoi:pub-id>
  12. O’Connell B, Lee EJ, Schiffer CA. The value of the 10-minute posttransfusion platelet counts. Transfusion 1988;28:66–7.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1046/j.1537-2995.1988.28188127957.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1537-2995.1988.28188127957.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">3341070</dgpm:pub-id>
  13. Duquesnoy RJ, Anderson AJ, Tomasulo PA, et al. ABO incompatibility and platelet transfusions of alloimmunized thrombocytopenic patients. Blood 1979;54:595–9.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1182/blood.V54.3.595.595" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1182/blood.V54.3.595.595</a></dgdoi:pub-id>
  14. Brand A, Sintnicolaas K, Claas FHJ, Eernisse JG. ABH antibodies causing platelet refractoriness. Transfusion 1986;26:463–6.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1046/j.1537-2995.1986.26587020127.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1537-2995.1986.26587020127.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">3532447</dgpm:pub-id>
  15. Heal JM, Blumberg N, Masel D. An evaluation of crossmatching, HLA and ABO matching for platelet transfusions to refractory patients. Blood 1987;70:23–30.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1182/blood.V70.1.23.23" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1182/blood.V70.1.23.23</a></dgdoi:pub-id>
  16. Lee EJ, Schiffer CA. ABO compatibility can influence the results of platelet transfusion: results of a randomized trial. Transfusion 1989;29:384–9.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1046/j.1537-2995.1989.29589284135.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1537-2995.1989.29589284135.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">2660333</dgpm:pub-id>
  17. Carr R, Hutton JL, Jenkins JA, et al. Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. Br J Haematol 1990;75:408–13.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1365-2141.1990.tb04356.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1365-2141.1990.tb04356.x</a></dgdoi:pub-id>
  18. Zoes C, Dube VE, Miller HJ, et al. Anti-A<sub>1</sub> in the plasma of platelet concentrates causing hemolytic reaction. Transfusion 1977;17:29–32.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1046/j.1537-2995.1977.17177128880.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1537-2995.1977.17177128880.x</a></dgdoi:pub-id>
  19. McLeod BC, Sassetti RJ, Weens JH, et al. Hemolytic transfusion reaction due to ABO-incompatibile plasma in platelet concentrate. Scan J Haematol 1982;28:193–6.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1600-0609.1982.tb00514.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1600-0609.1982.tb00514.x</a></dgdoi:pub-id>
  20. Conway LT, Scott EP. Acute hemolytic transfusion reaction due to ABO incompatible plasma in a plateletpheresis concentrate (letter). Transfusion 1984;24:413–4.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1046/j.1537-2995.1984.24585017836.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1537-2995.1984.24585017836.x</a></dgdoi:pub-id>
  21. Pierce RN, Reich LM, Mayer K. Hemolysis following platelet transfusions from ABO-incompatible donors. Transfusion 1985;25:60–2.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1046/j.1537-2995.1985.25185116506.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1537-2995.1985.25185116506.x</a></dgdoi:pub-id>
  22. Murphy MF, Hook S, Waters AH, et al. Acute haemolysis after ABO-incompatible platelet transfusions. Lancet 1990;1:974.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/0140-6736(90)91040-H" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/0140-6736(90)91040-H</a></dgdoi:pub-id>
  23. Goldfinger D, McGinniss MH. Rh-incompatible platelet transfusion—risks and consequences of sensitizing immunosuppressed patients. N Engl J Med 1971;284:942–4.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1056/NEJM197104292841704" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1056/NEJM197104292841704</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">4994614</dgpm:pub-id>
  24. Murphy MF, Waters AH. Immunological aspects of platelet transfusions. Br J Haematol 1985;60:409.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1365-2141.1985.tb07437.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1365-2141.1985.tb07437.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">4015986</dgpm:pub-id>
  25. Kickler TS. The platelet transfusion refractory state: transfusion practices and clinical management. In: Kurtz SR, Brubaker DB, eds. Clinical decisions in platelet therapy. Bethesda, MD: American Association of Blood Banks, 1992;97:89–92.
  26. Pegels JG, Bruynes ECE, Englefriet CP, von dem Bourne AEGKr. Serological studies in patients on platelet and granulocyte substitution therapy. Br J Haematol 1982;52:59–68.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1365-2141.1982.tb03861.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1365-2141.1982.tb03861.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">7115629</dgpm:pub-id>
  27. Duquesnoy RJ, Filip DJ, Rodney GE, et al. Successful transfusion of platelets “mismatched” for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol 1977;2:219–26.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1002/ajh.2830020303" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/ajh.2830020303</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">596366</dgpm:pub-id>
  28. Dahlke MB, Weiss KL. Platelet transfusion from donor mismatched for crossreactive HLA antigens. Transfusion 1984;24:299–302.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1046/j.1537-2995.1984.24484275567.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1537-2995.1984.24484275567.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">6464151</dgpm:pub-id>
  29. Schiffer CA, O’Connell B, Lee EJ. Platelet transfusion therapy for alloimmunized patients. Selective mismatching for HLA B12, an antigen with variable expression on platelets. Blood 1989;74:1172–6.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1182/blood.V74.3.1172.1172" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1182/blood.V74.3.1172.1172</a></dgdoi:pub-id>
  30. O’Connell BA, Schiffer CA. Donor selection for alloimmunized patients by platelet crossmatching of random-donor platelet concentrates. Transfusion 1990;30:314–7.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1046/j.1537-2995.1990.30490273438.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1537-2995.1990.30490273438.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">2349631</dgpm:pub-id>
  31. Kickler TS, Kennedy SD, Braine HG. Alloimmunization to platelet specific antigens on GPIIB-IIIA in multitransfused thrombocytopenic patients. Transfusion 1990;30:622–5.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1046/j.1537-2995.1990.30790385520.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1537-2995.1990.30790385520.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">2402776</dgpm:pub-id>
  32. McGrath K, Wolf M, Bishop J, et al. Transient platelet and HLA antibody formation in multitransfused patients with malignancy. Br J Haematol 1988;68:345–50.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1365-2141.1988.tb04212.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1365-2141.1988.tb04212.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">3355793</dgpm:pub-id>
  33. Capture-P® direction circular. Norcross, GA: Immucor, Inc.
  34. MCP® direction circular, Norcross, GA: Immucor, Inc.
  35. Capture-P® Ready-Screen® direction circular. Norcross, GA: Immucor, Inc.
  36. GTI-PAK<sup>TM</sup> 2 direction circular. Brookville, WI: GTI.
  37. Thrombomatch EIA direction circular. Dreieich, Germany: Biotest.
  38. Freedman J, Hooi C, Garvey MB. Prospective platelet crossmatching for selection of compatible random donors. Br J Haematol 1984;56:9–18.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1365-2141.1984.tb01267.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1365-2141.1984.tb01267.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">6367808</dgpm:pub-id>
  39. Ware R, Reisner EG, Rosse WF. The use of radiolabeled and fluorescein-labeled antiglobulins in assays to predict platelet transfusion outcome. Blood 1984;63:1245–8.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1182/blood.V63.5.1245.1245" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1182/blood.V63.5.1245.1245</a></dgdoi:pub-id>
  40. Rachel JM, Sinor LT, Tawfik OW, et al. A solid-phase red cell adherence test for platelet cross-matching. Med Lab Sci 1985;42:194–5.
  41. Freedman J, Gafni A, Garvey MB, Blanchette V. A cost-effective evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients. Transfusion 1989;29:201–7.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1046/j.1537-2995.1989.29389162723.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1537-2995.1989.29389162723.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">2493693</dgpm:pub-id>
  42. Kickler TS, Ness PM, Braine HG. Platelet crossmatching: a direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient. Am J Clin Pathol 1988;90:69–72.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1093/ajcp/90.1.69" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/ajcp/90.1.69</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">3389345</dgpm:pub-id>
  43. Rachel JM, Summers TC, Sinor LT, Plapp FV. Use of a solid phase red blood cell adherence method for pretransfusion platelet compatibility testing. Am J Clin Pathol 1988;90:63–8.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1093/ajcp/90.1.63" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/ajcp/90.1.63</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">3389344</dgpm:pub-id>
  44. O’Connell BA, Lee EJ, Rothko K, et al. Selection of histocompatible apheresis platelet donors by crossmatching random donor platelet concentrates. Blood 1992;79:527–31.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1182/blood.V79.2.527.527" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1182/blood.V79.2.527.527</a></dgdoi:pub-id>
  45. Lee EJ, Schiffer CA. Serial measurement of lymphocytotoxic antibody and response to nonmatched platelet transfusions in alloimmunized patients. Blood 1987;70:1727–9.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1182/blood.V70.6.1727.1727" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1182/blood.V70.6.1727.1727</a></dgdoi:pub-id>
DOI: https://doi.org/10.21307/immunohematology-2019-804 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 133 - 139
Published on: Nov 17, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2020 S. Rolih, published by American National Red Cross
This work is licensed under the Creative Commons License.